Biotherapeutics

Show results for

Unknown (1607)
Genomics (43)
Proteomics (36)
Transcriptomics (10)
Other (2)

Organisms

Chlamydomonas reinhardtii (25)
Marchantia polymorpha subsp. ruderalis (25)
Methylocystis sp. (25)
Porites pukoensis (25)
Bothrops insularis (25)
Bothrops jararaca (25)
Bothrops jararacussu (25)
Bothrops cotiara (25)
Streptomyces coelicolor (25)
Burkholderia ubonensis MSMB22 (25)
Pseudomonas aeruginosa PA103 (25)
Artibeus jamaicensis (25)
Morchella importuna (25)
Shewanella oneidensis MR-1 (25)
Leucocoprinus gongylophorus (25)
Bothrops brazili (25)
Ixodes scapularis (25)
Bothrops leucurus (25)
Bothrops moojeni (25)
Pseudomonas syringae (25)
Sclerotinia sclerotiorum (25)
Tabanus autumnalis (25)
Brassica napus (25)
Homo sapiens (4)
mouse gut metagenome (3)
Cricetulus griseus (3)
Komagataella phaffii (2)
Mus musculus (2)
Bacteroides thetaiotaomicron (1)
Macaca fascicularis (1)

Organisms

Mus musculus (7)
Homo sapiens (6)
Cricetulus griseus (2)
Komagataella phaffii (2)
prokaryote coculture (1)
Macaca fascicularis (1)
activated sludge metagenome (1)
mouse gut metagenome (1)
Enterococcus faecium (1)

Repository

ENA (43)
pride (25)
geo (11)
MassIVE (9)
biostudies-arrayexpress (1)
iProX (1)
PanoramaPublic (1)

Tissue

Cell culture (6)
Epithelial cell (4)
Keratinocyte (2)
Skin (2)
Plasma cell (1)
Skin fibroblast (1)
Epidermal keratinocyte (1)
Venom (1)
Mesenchymal cell (1)
Brain (1)
Cell suspension culture (1)
Dendritic cell (1)
Primary cell (1)

Disease

Wounds and Injuries (2)
Pancreatic carcinoma (1)
Alzheimer's disease 1 (1)
Prostate adenocarcinoma (1)
Cervix carcinoma (1)
Melanoma (1)
Breast cancer (1)

Technology Type

Mass Spectrometry (25)
Bottom-up proteomics (10)
Data-dependent acquisition (7)
Data-independent acquisition (6)
Top-down proteomics (6)
Shotgun proteomics (4)
Affinity purification coupled with mass spectrometry proteomics (3)
MSE (2)
Mass spectrometry imaging (1)
Immunopeptidomics (1)
SWATH MS (1)
SRM/MRM (1)

Instrument Platform

Q Exactive HF-X (2)
Orbitrap Fusion Lumos (2)
Orbitrap Ascend (1)
Q Exactive UHMR (1)
Orbitrap Astral (1)
Orbitrap Eclipse (1)
TimsTOF Pro (1)

Publication Date

2026 (15)
2025 (10)
2022 (5)
2023 (5)
2024 (4)
2020 (2)
2011 (1)
2019 (1)
2021 (1)
2016 (1)
2014 (1)

First Public Date

2025 (10)
2026 (9)
2024 (7)
2022 (5)
2023 (4)
2020 (4)
2021 (2)
2016 (1)
2014 (1)

Classification

bacteria (1)

Modification

Not available (1)

Study type

RNA-seq of coding RNA (1)

Release Date

2022 (242)
2025 (196)
2021 (183)
2024 (174)
2023 (170)
2020 (139)
2018 (88)
2019 (73)
2016 (73)
2017 (64)
2015 (57)
2014 (33)
2013 (30)
2012 (19)
2010 (16)
2011 (13)
2026 (12)
2009 (7)
2008 (4)
2004 (4)
2007 (3)
2003 (3)
2002 (3)
2006 (2)

Lab affiliation

A2 Biotherapeutics (2)
Section for Protein Science and Biotherapeutics, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, 2800, Kongens Lyngby, Denmark (2)
University of Applied Sciences Albstadt-Sigmaringen, Department of Life Sciences, Anton-Günther-Straße 51, 72488 Sigmaringen, Germany (1)
Professor of Chemical Enginnering Department Indian Institute of Technology Delhi (1)
Denali Therapeutics (1)
Immunocore, Milton, UK (1)
Senior Principal Scientist I,Bioprocessing Technology Institute, A*Star, Singapore Adjunct Associate Professor, Duke-NUS Medical School, Singapore Adjunct Associate Professor,Singapore Institute of Technology, Singapore (1)
Institute of Chemistry, Universidade Federal do Rio de Janeiro Av Athos da Silveira Ramos, 149, CT- A-542, Cidade Universitária 21941-909 Rio de Janeiro, RJ Brazil (1)
Université Claude Bernard Lyon1, ISA, UMR5280, CNRS, Villeurbanne, France (1)
Professor & Head, Manipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Karnataka, Manipal, 576 104, India (1)
Roche (1)
FDA (1)
Immunespec Niel, Belgium (1)
Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Korea (1)
Institute of Biomedical Chemistry (1)
University Paris-Saclay, INRAe, AgroParisTech, Micalis Institute, FRANCE (1)
Clinical and Health Sciences, Mass Spectrometry and Proteomics facility, University of South Australia, Adelaide, Australia (1)
National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland, A94 X099 School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin 4, Ireland, D04 V1W8. (1)
Michael Barber Centre for Collaborative Mass Spectrometry Manchester Institute of Biotechnology Department of Chemistry The University of Manchester (1)
Spectroswiss, Switzerland (1)
Université Paris-Saclay, CEA, CNRS, NIMBE, LIONS, 91191 Gif-sur-Yvette, France (1)
Glycoproteomics Laboratory, Institute of Biomedical Sciences, University of São Paulo (1)
Technical Research & Development, GSK (1)

Previous page
1 / 170
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 170
Next page

Sort by:

Relevance

Page size

Intrinsic physicochemical profile of marketed antibody-based biotherapeutics.

Not available

S-EPMC8449350 | biostudies-literature

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics.

Not available

S-EPMC10072077 | biostudies-literature

Embedding Dynamics in Intrinsic Physicochemical Profiles of Market-Stage Antibody-Based Biotherapeutics.

Not available

S-EPMC9906779 | biostudies-literature

An adapted consensus protein design strategy for identifying globally optimal biotherapeutics.

Not available

S-EPMC9135432 | biostudies-literature

Exposing the molecular heterogeneity of glycosylated biotherapeutics.

Not available

S-EPMC11021452 | biostudies-literature

Design and engineering of deimmunized biotherapeutics.

Not available

S-EPMC5067179 | biostudies-literature

Ferritin - a multifaceted protein scaffold for biotherapeutics.

Not available

S-EPMC9527718 | biostudies-literature

Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.

Not available

S-EPMC4340091 | biostudies-literature

CD98hc is a target for brain delivery of biotherapeutics

Brain exposure of systemically administered biotherapeutics is highly restricted by the blood-brain barrier (BBB). Here, we report the engineering and characterization of a BBB transport vehicle targeting the CD98 heavy chain (CD98hc or SLC3A2) of heterodimeric amino acid transporters (TV^CD98hc). T...

ORGANISM(S): Homo sapiens (Human)

2023-07-31 | PXD044159 | Pride

Data-independent oxonium ion profiling of multi-glycosylated biotherapeutics.

Not available

S-EPMC6204843 | biostudies-literature

Previous page
1 / 170
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 170
Next page

Sort by:

Relevance

Page size

1698 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

First Public Date

Classification

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets